Skip to Main Content

Paper Details

Isatuximab as monotherapy and combined with dexamethasone in patients with relapsed/refractory multiple myeloma.
Blood
40
2021
Infusion reactions, Isa, Patients, RRMM, dex, dexamethasone, hematologic abnormalities, isatuximab, multiple myeloma, patients, relapsed/refractory multiple myeloma
Author NameAffiliation
Ravi VijWashington University
  • 1 - 1

Datasets

Release 1.2